Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

VCCP

- PMLiVE

FDA panel backs Pfizer and Teva abuse-resistant painkillers

Recommends long-acting opioid analgesics Troxyca ER and Vantrela ER for approval

- PMLiVE

GSK signs up for the ‘dawn of cognitive advertising’

Its consumer health arm is among the first to use new IBM offering Watson Ads

Teva Pharma logo

FDA turns down Teva’s Huntington’s disease drug

Has requested further analysis on certain metabolites of the chorea candidate

- PMLiVE

Catalyx and Health Agency form strategic partnership

Will create targeted healthcare campaigns with crowdsourced intelligence

- PMLiVE

SEO for the healthcare industry

Gaining online visibility in any disease area remains a challenge for marketers

- PMLiVE

Business as usual

MHRA explains that its emphasis will remain firmly on vetting when it comes to pharma advertising

Publicis

Langland opens New York office

Marks the UK health advertising agency's first over-seas venture

- PMLiVE

Science doesn’t sell

Healthcare communications aren’t lacking in clinical data - what they need is a dose of advertising ideals

Syneos Health®

- PMLiVE

Science doesn’t sell

Healthcare communications aren’t lacking in clinical data - what they need is a dose of advertising ideals

- PMLiVE

Concentric Health Experience eyes European expansion

Appoints Peter Carr and Arron O’Hare as part of regional expansion plans

- PMLiVE

Teva and Takeda appoint head of Japanese generics venture

Hiroshi Matsumori will lead partnership of Teva’s generics portfolio and Takeda brands

- PMLiVE

FDA approves new drugs from Teva, Lilly and Elusys

Cinqair, Taltz and Anthim have all been given the green light in the US

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links